Please note that some translations using Google Translate may not be accurately represented, and image captions and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result for using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
The Center for Sarcoma and Bone Oncology at Dana-Farber Cancer Institute — one of the largest and most respected sarcoma programs in the world — is leading critical efforts toward understanding the specific genetic changes that cause sarcomas. New findings inform the design of innovative diagnostic techniques and treatments. Our recent investigations — of unprecedented depth and scope — aim to increase treatment efficacy through research into resistance mechanisms and novel therapeutics.
Diseases for which we conduct clinical trials include:
Read about our research for angiosarcomas.
Read about our research for Ewing's sarcoma.
Read about our research for GIST.
Read about our research for leiomyosarcoma and deconstructing heterogeneity in leiomyosarcoma.
Read about our research for liposarcoma.
Read about our research for osteosarcoma.
Read about our research for TGCT.
Find Dana-Farber's clinical trials for sarcoma.
Appointments and Second Opinions